Block copolymeric biotransport carriers as versatile vehicles for drug delivery
- 1 September 1998
- journal article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 7 (9), 1453-1473
- https://doi.org/10.1517/13543784.7.9.1453
Abstract
This review describes block co-polymer-based systems that are used in drug delivery. The main focus is on amphiphilic block co-polymers, the application of which modifies the pharmacological performance of various classes of drugs and is attracting more and more attention. The two main reasons for this are the high tendency of block co-polymer-based drug formulations to self-assemble and the flexibility of block co-polymer chemistry, which allows precise tailoring of the carrier to virtually any chemical entity. The combination of these and some other features makes it possible to adjust block co-polymer-based drug formulations to achieve the most beneficial balance in their biological interactions (biotransport), with systems that control drug removal from the body and those that are responsible for drug therapeutic activity. The following major aspects are considered:Keywords
This publication has 65 references indexed in Scilit:
- Use of rhodamine 123 to examine the functional activity of P-glycoprotein in primary cultured brain microvessel endothelial cell monolayersLife Sciences, 1996
- Enhancement of the polycation‐mediated DNA uptake and cell transfection with Pluronic P85 block copolymerFEBS Letters, 1996
- Effect of the P-Glycoprotein Inhibitor, Cyclosporine A, on the Distribution of Rhodamine-123 to the Brain: An in Vivo Microdialysis Study in Freely Moving RatsBiochemical and Biophysical Research Communications, 1995
- Polymer ConjugatesClinical Pharmacokinetics, 1994
- Neurotransmission: harnessing fusion machinery at the synapseTrends in Neurosciences, 1994
- Critical micellization phenomena in block polyelectrolyte solutionsMacromolecules, 1993
- Atypical multi-drug resistance (MDR)Anti-Cancer Drugs, 1993
- Multidrug resistance in human cancerCritical Reviews in Oncology/Hematology, 1992
- Quantitative Determination of Factors Contributing to Doxorubicin Resistance in Multidrug-Resistant CellsJNCI Journal of the National Cancer Institute, 1989
- Radiographic Blood Pool Contrast Agents for Vascular and Tumor Imaging with Projection Radiography and Computed TomographyJournal of Computer Assisted Tomography, 1982